GL1X · GenesisL1 explorer

Research workbench

Inhibiting alternative pathway complement activation by targeting the exosite on factor D

Analyse Inhibiting alternative pathway complement activation by targeting the exosite… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4D9R
Type
protein
Length
1,317 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Complement factor D; Fab light chain; Fab heavy chain
EC
3.4.21.46
UniProt
P00746, P01834, P01857
Ligands
CL
Pockets
12 · best druggability 0.63

Structure

x-ray diffraction · 5 distinct chains · 8% helix, 46% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BComplement factor D (EC 3.4.21.46)protein2289% helix, 34% strandP00746
LFab light chainprotein2147% helix, 50% strandP01834
HFab heavy chainprotein2188% helix, 49% strandP01857
EFab heavy chainprotein2168% helix, 50% strandP01857
DFab light chainprotein2137% helix, 50% strandP01834

Ligands and binding sites

  • CL · Chloride ion · ion · 2 copies · chains E, D, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16300.630.7459empty
26260.620.7461empty
34570.610.7559empty
41560.560.8124empty
51010.410.7718empty

Interfaces

8 interfaces between chains.

  • L–H · 1926 Ų buried · 19 hydrogen bonds · protein-protein
  • E–D · 1848 Ų buried · 17 hydrogen bonds · protein-protein
  • B–E · 584 Ų buried · 16 hydrogen bonds · protein-protein
  • A–H · 577 Ų buried · 14 hydrogen bonds · protein-protein
  • A–L · 399 Ų buried · 12 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 17 disulfide (disulfide).

Compared structures

  • 4D9R · Inhibiting Alternative Pathway Complement Activation by Targeting the Exosite on Factor D · the same entry in another collection · chain D against D, TM-score 1.00
  • P00746 · AlphaFold monomer V2.0 prediction for complement factor D (P00746) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • P01834 · AlphaFold monomer V2.0 prediction for immunoglobulin kappa constant (P01834) · a predicted model of the same protein · chain L against A, TM-score 0.50

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.